{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:05:36Z","timestamp":1746245136053,"version":"3.40.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,2]]},"DOI":"10.7759\/cureus.83342","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:58:32Z","timestamp":1746187112000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Management of Pregnancy in a Patient With Fabry Disease Receiving Continuous Enzyme Replacement Therapy: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Yuka","family":"Kido","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saya","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yojiro","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Ogishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.123.004252","article-title":"Impact of GLA variant classification on the estimated prevalence of Fabry disease: a systematic review and meta-analysis of screening studies","volume":"16","author":"Monda E","year":"2023","unstructured":"Monda E, Diana G, Graziani F, et al.. Impact of GLA variant classification on the estimated prevalence of Fabry disease: a systematic review and meta-analysis of screening studies. Circ Genom Precis Med. 2023, 16:e004252. 10.1161\/CIRCGEN.123.004252","journal-title":"Circ Genom Precis Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-011-9447-9","article-title":"Prevalence of symptoms in female Fabry disease patients: a case-control survey","volume":"35","author":"Bouwman MG","year":"2012","unstructured":"Bouwman MG, Rombach SM, Schenk E, Sweeb A, Wijburg FA, Hollak CE, Linthorst GE. Prevalence of symptoms in female Fabry disease patients: a case-control survey. J Inherit Metab Dis. 2012, 35:891-8. 10.1007\/s10545-011-9447-9","journal-title":"J Inherit Metab Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/8904_2014_384","article-title":"A retrospective survey studying the impact of Fabry disease on pregnancy","volume":"21","author":"Holmes A","year":"2015","unstructured":"Holmes A, Laney D. A retrospective survey studying the impact of Fabry disease on pregnancy. JIMD Rep. 2015, 21:57-63. 10.1007\/8904_2014_384","journal-title":"JIMD Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12228","article-title":"Developments in the treatment of Fabry disease","volume":"43","author":"van der Veen SJ","year":"2020","unstructured":"van der Veen SJ, Hollak CE, van Kuilenburg AB, Langeveld M. Developments in the treatment of Fabry disease. J Inherit Metab Dis. 2020, 43:908-21. 10.1002\/jimd.12228","journal-title":"J Inherit Metab Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann R","year":"2001","unstructured":"Schiffmann R, Kopp JB, Austin HA 3rd, et al.. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA. 2001, 285:2743-9. 10.1001\/jama.285.21.2743","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-005-0018-9","article-title":"Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa","volume":"28","author":"Wendt S","year":"2005","unstructured":"Wendt S, Whybra C, Kampmann C, Teichmann E, Beck M. Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa. J Inherit Metab Dis. 2005, 28:787-8. 10.1007\/s10545-005-0018-9","journal-title":"J Inherit Metab Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2009.01.007","article-title":"Enzyme replacement therapy with agalsidase alfa in pregnant women with Fabry disease","volume":"144","author":"Kalkum G","year":"2009","unstructured":"Kalkum G, Macchiella D, Reinke J, K\u00f6lbl H, Beck M. Enzyme replacement therapy with agalsidase alfa in pregnant women with Fabry disease. Eur J Obstet Gynecol Reprod Biol. 2009, 144:92-3. 10.1016\/j.ejogrb.2009.01.007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3109\/14767050903580391","article-title":"Fabry disease complicating pregnancy","volume":"23","author":"Parent E","year":"2010","unstructured":"Parent E, Wax JR, Smith W, Blaszyk H, Pinette MG, Cartin A, Blackstone J. Fabry disease complicating pregnancy. J Matern Fetal Neonatal Med. 2010, 23:1253-6. 10.3109\/14767050903580391","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2009.12.004","article-title":"Uneventful pregnancy outcome after enzyme replacement therapy with agalsidase beta in a heterozygous female with Fabry disease: a case report","volume":"53","author":"Germain DP","year":"2010","unstructured":"Germain DP, Bruneval P, Tran TC, Balouet P, Richalet B, Benistan K. Uneventful pregnancy outcome after enzyme replacement therapy with agalsidase beta in a heterozygous female with Fabry disease: a case report. Eur J Med Genet. 2010, 53:111-2. 10.1016\/j.ejmg.2009.12.004","journal-title":"Eur J Med Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2010.02.004","article-title":"Analysis of placental tissue in Fabry disease with and without enzyme replacement therapy","volume":"31","author":"Bouwman MG","year":"2010","unstructured":"Bouwman MG, Hollak CE, van den Bergh Weerman MA, Wijburg FA, Linthorst GE. Analysis of placental tissue in Fabry disease with and without enzyme replacement therapy. Placenta. 2010, 31:344-6. 10.1016\/j.placenta.2010.02.004","journal-title":"Placenta"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2009.01164.x","article-title":"Treatment with agalsidase beta during pregnancy in Fabry disease","volume":"36","author":"Politei JM","year":"2010","unstructured":"Politei JM. Treatment with agalsidase beta during pregnancy in Fabry disease. J Obstet Gynaecol Res. 2010, 36:428-9. 10.1111\/j.1447-0756.2009.01164.x","journal-title":"J Obstet Gynaecol Res"},{"key":"ref12","article-title":"Safe and successful treatment with agalsidase beta during pregnancy in Fabry disease","volume":"9","author":"Senocak Tasci E","year":"2015","unstructured":"Senocak Tasci E, Bicik Z. Safe and successful treatment with agalsidase beta during pregnancy in Fabry disease. Iran J Kidney Dis. 2015, 9:406-8.","journal-title":"Iran J Kidney Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-017-0277-y","article-title":"Enzyme replacement therapy in a patient of heterozygous Fabry disease: clinical and pathological evaluations by repeat kidney biopsy and a successful pregnancy","volume":"6","author":"Iwafuchi Y","year":"2017","unstructured":"Iwafuchi Y, Maruyama H, Morioka T, Noda S, Nagata H, Oyama Y, Narita I. Enzyme replacement therapy in a patient of heterozygous Fabry disease: clinical and pathological evaluations by repeat kidney biopsy and a successful pregnancy. CEN Case Rep. 2017, 6:210-4. 10.1007\/s13730-017-0277-y","journal-title":"CEN Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/8904_2018_141","article-title":"Enzyme replacement therapy in pregnant women with Fabry disease: a case series","volume":"45","author":"Fern\u00e1ndez P","year":"2019","unstructured":"Fern\u00e1ndez P, Fern\u00e1ndez SO, Gonzalez JG, Fern\u00e1ndez T, Fern\u00e1ndez CC, Fern\u00e1ndez SP. Enzyme replacement therapy in pregnant women with Fabry disease: a case series. JIMD Rep. 2019, 45:77-81. 10.1007\/8904_2018_141","journal-title":"JIMD Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/8904_2018_129","article-title":"Enzyme replacement therapy during pregnancy in Fabry patients: review of published cases of live births and a new case of a severely affected female with Fabry disease and pre-eclampsia complicating pregnancy","volume":"44","author":"Madsen CV","year":"2019","unstructured":"Madsen CV, Christensen EI, Nielsen R, Mogensen H, Rasmussen \u00c5K, Feldt-Rasmussen U. Enzyme replacement therapy during pregnancy in Fabry patients: review of published cases of live births and a new case of a severely affected female with Fabry disease and pre-eclampsia complicating pregnancy. JIMD Rep. 2019, 44:93-101. 10.1007\/8904_2018_129","journal-title":"JIMD Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijoa.2023.103958","article-title":"Cesarean section under spinal anesthesia in a first-time gravida with Fabry disease","volume":"57","author":"Politt K","year":"2024","unstructured":"Politt K, Gaik C. Cesarean section under spinal anesthesia in a first-time gravida with Fabry disease. Int J Obstet Anesth. 2024, 57:103958. 10.1016\/j.ijoa.2023.103958","journal-title":"Int J Obstet Anesth"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/1744-9987.14081","article-title":"Two successful pregnancies in a woman with Fabry continuing enzyme replacement therapy","volume":"28","author":"Paydas S","year":"2024","unstructured":"Paydas S, Akcabay C. Two successful pregnancies in a woman with Fabry continuing enzyme replacement therapy. Ther Apher Dial. 2024, 28:329-30. 10.1111\/1744-9987.14081","journal-title":"Ther Apher Dial"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2019.07.004","article-title":"The two-stage placental model of preeclampsia: an update","volume":"134-135","author":"Staff AC","year":"2019","unstructured":"Staff AC. The two-stage placental model of preeclampsia: an update. J Reprod Immunol. 2019, 134-135:1-10. 10.1016\/j.jri.2019.07.004","journal-title":"J Reprod Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2011.07.020","article-title":"Histologic abnormalities of placental tissues in Fabry disease: a case report and review of the literature","volume":"43","author":"Thurberg BL","year":"2012","unstructured":"Thurberg BL, Politei JM. Histologic abnormalities of placental tissues in Fabry disease: a case report and review of the literature. Hum Pathol. 2012, 43:610-4. 10.1016\/j.humpath.2011.07.020","journal-title":"Hum Pathol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-024-03180-3","article-title":"Pregnancy outcomes of Fabry disease in Austria (PROFABIA)-a retrospective cohort-study","volume":"19","author":"Haninger-Vacariu N","year":"2024","unstructured":"Haninger-Vacariu N, Anastopoulos K, Aigner C, et al.. Pregnancy outcomes of Fabry disease in Austria (PROFABIA)-a retrospective cohort-study. Orphanet J Rare Dis. 2024, 19:165. 10.1186\/s13023-024-03180-3","journal-title":"Orphanet J Rare Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/351062-successful-management-of-pregnancy-in-a-patient-with-fabry-disease-receiving-continuous-enzyme-replacement-therapy-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:58:32Z","timestamp":1746187112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/351062-successful-management-of-pregnancy-in-a-patient-with-fabry-disease-receiving-continuous-enzyme-replacement-therapy-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.83342","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,2]]}}}